Novel β-Cyclodextrin-Based Heptavalent Glycyrrhetinic Acid Conjugates: Synthesis, Characterization, and Anti-Influenza Activity - Archive ouverte HAL
Article Dans Une Revue Frontiers in Chemistry Année : 2022

Novel β-Cyclodextrin-Based Heptavalent Glycyrrhetinic Acid Conjugates: Synthesis, Characterization, and Anti-Influenza Activity

Résumé

In our continuing efforts toward the design of novel pentacyclic triterpene derivatives as potential anti-influenza virus entry inhibitors, a series of homogeneous heptavalent glycyrrhetinic acid derivatives based on β -cyclodextrin scaffold were designed and synthesized by click chemistry. The structure was unambiguously characterized by NMR, IR, and MALDI-TOF-MS measurements. Seven conjugates showed sufficient inhibitory activity against influenza virus infection based on the cytopathic effect reduction assay with IC 50 values in the micromolar range. The interactions of conjugate 37 , the most potent compound (IC 50 = 2.86 μ M, CC 50 > 100 μ M), with the influenza virus were investigated using the hemagglutination inhibition assay. Moreover, the surface plasmon resonance assay further confirmed that compound 37 bound to the influenza HA protein specifically with a dissociation constant of 5.15 × 10 −7 M. Our results suggest the promising role of β -cyclodextrin as a scaffold for preparing a variety of multivalent compounds as influenza entry inhibitors.
Fichier principal
Vignette du fichier
2022, 10, 836955 Frontiers in Chemistry.pdf (979.42 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03643460 , version 1 (15-04-2022)

Identifiants

Citer

Shuobin Liang, Xinyuan Ma, Man Li, Yanliang Yi, Qianqian Gao, et al.. Novel β-Cyclodextrin-Based Heptavalent Glycyrrhetinic Acid Conjugates: Synthesis, Characterization, and Anti-Influenza Activity. Frontiers in Chemistry, 2022, 10, pp.836955. ⟨10.3389/fchem.2022.836955⟩. ⟨hal-03643460⟩
135 Consultations
55 Téléchargements

Altmetric

Partager

More